Skip to main content
Log in

Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

The loudness dependence of the auditory evoked potential (LDAEP) has been reported to be an effective non-invasive measure of central serotonergic neurotransmission. However, acute manipulations of the serotonergic system in humans and animals have yielded inconsistent findings.

Objectives

In this study, we examined the chronic effect of serotonergic manipulation using the selective serotonin reuptake inhibitor, sertraline, on the LDAEP. In addition, we examined the influence of 5-HTTLPR genotype and individual differences in plasma drug concentrations on the LDAEP.

Methods

The study utilised a double-blind, placebo-controlled, between-group design in which 40 (24 female) healthy adults (M age = 22.0 years, SE = 0.7) were tested following placebo or sertraline for an average of 24 days. The LDAEP was assessed 6 h post-final dose, and changes in the slope of amplitude of the N1/P2 across intensities (60, 70, 80, 90, 100 dB) were examined at Cz.

Results

The sertraline group had a significantly smaller LDAEP than the placebo group [F(1,38) = 5.97, p = 0.02]. Drug plasma levels did not correlate with the LDAEP in the sertraline group, and there was no influence of 5-HTTLPR genotype.

Conclusions

We show for the first time that chronically modulating serotonin neurotransmission alters the LDAEP in healthy adults, consistent with extant literature indicating a moderating role of serotonin on this neurophysiological biomarker. The findings from this study together with previous studies suggest that the LDAEP may be a more sensitive marker of long-term or chronic rather than acute changes in the serotonin system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Notes

  1. Several studies have reported that a stronger baseline LDAEP in MDD patients predicts a more favourable response to SSRI treatment than patients with a weaker LDAEP (Gallinat et al. 2000; Juckel et al. 2007; Mulert et al. 2007).

References

  • AARP Bulletin Today. (2009) The 50 most prescribed drugs. From http://assets.aarp.org/www.aarp.org_/articles/bulletin/interactive/powerof50/oct09/index.html. Accessed 10 November 2010

  • Anderson GM, Bennett AJ, Weld KP, Pushkas JG, Ocame DM, Higley JD (2002) Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: basal levels and effects of sertraline administration. Psychopharmacology (Berl) 161(1):95–99

    Article  CAS  Google Scholar 

  • Arce E, Simmons AN, Lovero KL, Stein MB, Paulus MP (2008) Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 196(4):661–672

    Article  CAS  Google Scholar 

  • Aznavour N, Rbah L, Riad M, Reilhac A, Costes N, Descarries L et al (2006) A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment. Neuroimage 33(3):834–842

    Article  PubMed  Google Scholar 

  • Beck AT, Steer RA (1987) Beck depression inventory manual. HBJ, San Antonio

    Google Scholar 

  • Benedetti F, Colombo C, Serretti A, Lorenzi C, Pontiggia A, Barbini B et al (2003) Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Biol Psychiatry 54(7):687–692

    Article  PubMed  CAS  Google Scholar 

  • Beyer CE, Cremers TI (2008) Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin? Eur J Pharmacol 580(3):350–354

    Article  PubMed  CAS  Google Scholar 

  • Brett MA, Dierdorf HD, Zussman BD, Coates PE (1987) Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatography 419:438–444

    Article  CAS  Google Scholar 

  • Brocke B, Beauducel A, John R, Debener S, Heilemann H (2000) Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 41(1):24–30

    Article  PubMed  CAS  Google Scholar 

  • Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE (2004) The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55(12):1171–1178

    Article  PubMed  CAS  Google Scholar 

  • Carrillo-de-la-Pena MT (2001) One-year test–retest reliability of auditory evoked potentials (AEPs) to tones of increasing intensity. Psychophysiology 38(3):417–424

    Article  PubMed  CAS  Google Scholar 

  • Carver CS, Miller CJ (2006) Relations of serotonin function to personality: current views and a key methodological issue. Psychiatry Res 144(1):1–15

    Article  PubMed  CAS  Google Scholar 

  • Chen TJ, Yu YW, Chen MC, Tsai SJ, Hong CJ (2002) Association analysis for serotonin transporter promoter polymorphism and auditory evoked potentials for major depression. Neuropsychobiology 46(2):57–60

    Article  PubMed  CAS  Google Scholar 

  • Connolly JF, Gruzelier JH (1982) Amplitude and latency changes in the visual evoked potential to different stimulus intensities. Psychophysiology 19(6):599–608

    Article  PubMed  CAS  Google Scholar 

  • Cook EW, 3rd. (2000) VPM reference manual (version 11.2). University of Alabama, Birmingham

  • Croft RJ, Klugman A, Baldeweg T, Gruzelier JH (2001) Electrophysiological evidence of serotonergic impairment in long-term MDMA (“ecstasy”) users. Am J Psychiatry 158(10):1687–1692

    Article  PubMed  CAS  Google Scholar 

  • Debener S, Strobel A, Kurschner K, Kranczioch C, Hebenstreit J, Maercker A et al (2002) Is auditory evoked potential augmenting/reducing affected by acute tryptophan depletion? Biol Psychol 59(2):121–133

    Article  PubMed  Google Scholar 

  • Deecher D, Andree TH, Sloan D, Schechter LE (2008) From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 33(1):3–17

    Article  PubMed  Google Scholar 

  • Derogatis L (1977) SCL-90-R version: manual I. John Hopkins University Press, Baltimore

    Google Scholar 

  • Doogan DP (1991) Toleration and safety of sertraline: experience worldwide. Int Clin Psychopharmacol 6(Suppl 2):47–56

    Article  PubMed  Google Scholar 

  • Eichhammer P, Langguth B, Wiegand R, Kharraz A, Frick U, Hajak G (2003) Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology (Berl) 166(3):294–297

    CAS  Google Scholar 

  • First MB, Spitzer RL, Gibbon M, Williams JBW (1994) Structured clinical interview for Axis I DSM-IV disorders. New York State Psychiatric Institute, New York

    Google Scholar 

  • Fitzgerald PB, Mellow TB, Hoy KE, Segrave R, Cooper NR, Upton DJ et al (2009) A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and non-melancholic depression. J Affect Disord 117(3):212–216

    Article  PubMed  Google Scholar 

  • Furlan PM, Kallan MJ, Have TT, Lucki I, Katz I (2004) SSRIs do not cause affective blunting in healthy elderly volunteers. Am J Geriatr Psychiatry 12(3):323–330

    PubMed  Google Scholar 

  • Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ et al (2000) The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berlin) 148(4):404–411

    Article  CAS  Google Scholar 

  • Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T et al (2003) Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 28(3):530–532

    Article  PubMed  CAS  Google Scholar 

  • Gelernter J, Kranzler H, Cubells JF (1997) Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet 101(2):243–246

    Article  PubMed  CAS  Google Scholar 

  • Gelernter J, Kranzler H, Coccaro EF, Siever LJ, New AS (1998) Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry 155(10):1332–1338

    PubMed  CAS  Google Scholar 

  • Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK (1999) Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 88(1):61–66

    Article  PubMed  CAS  Google Scholar 

  • Gressier F, Bouaziz E, Verstuyft C, Hardy P, Becquemont L, Corruble E (2009) 5-HTTLPR modulates antidepressant efficacy in depressed women. Psychiatr Genet 19(4):195–200

    Article  PubMed  Google Scholar 

  • Gudlowski Y, Ozgurdal S, Witthaus H, Gallinat J, Hauser M, Winter C et al (2009) Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 109(1–3):141–147

    Article  PubMed  Google Scholar 

  • Guille V, Croft RJ, O’Neill BV, Illic S, Phan KL, Nathan PJ (2008) An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacology 23(3):231–241

    Article  CAS  Google Scholar 

  • Hariri AR, Holmes A (2006) Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 10(4):182–191

    Article  PubMed  Google Scholar 

  • Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28(1):148–152

    Article  PubMed  CAS  Google Scholar 

  • Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33(3):173–187

    Article  PubMed  CAS  Google Scholar 

  • Hegerl U, Karnauchow I, Herrmann WM, Muller-Oerlinghausen B (1992) Intensity dependence of auditory evoked N1/P2 component and personality. Neuropsychobiology 26(3):166–172

    Article  PubMed  CAS  Google Scholar 

  • Hegerl U, Gallinat J, Mrowinski D (1994) Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17(1):1–13

    Article  PubMed  CAS  Google Scholar 

  • Hegerl U, Gallinat J, Mrowinski D (1995) Sensory cortical processing and the biological basis of personality. Biol Psychiatry 37(7):467–472

    Article  PubMed  CAS  Google Scholar 

  • Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62(1–2):93–100

    Article  PubMed  CAS  Google Scholar 

  • Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A et al (2009) Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry 195(1):30–38

    Article  PubMed  Google Scholar 

  • Hutchison KE, Stallings M, McGeary J, Bryan A (2004) Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull 130(1):66–79

    Article  PubMed  Google Scholar 

  • Hyttel J (1993) Comparative pharmacology of selective serotonin re-uptake inhibitors (SSRIs). Nord J Psychiatry 47(S30):5–12

    Article  Google Scholar 

  • Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9(Suppl 1):19–26

    Article  PubMed  Google Scholar 

  • Jensen JB, Jessop DS, Harbuz MS, Mork A, Sanchez C, Mikkelsen JD (1999) Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 11(6):465–471

    Article  PubMed  CAS  Google Scholar 

  • Jovanovic H, Karlsson P, Cerin A, Halldin C, Nordstrom AL (2009) 5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET. Psychiatry Res 172(1):31–37

    Article  PubMed  CAS  Google Scholar 

  • Juckel G, Schmidt LG, Rommelspacher H, Hegerl U (1995) The Tridimensional Personality Questionnaire and the intensity dependence of auditory evoked dipole source activity. Biol Psychiatry 37(5):311–317

    Article  PubMed  CAS  Google Scholar 

  • Juckel G, Csepe V, Molnar M, Hegerl U, Karmos G (1996) Intensity dependence of auditory evoked potentials in behaving cats. Electroencephalogr Clin Neurophysiol 100(6):527–537

    Article  PubMed  CAS  Google Scholar 

  • Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G (1997) Auditory-evoked potentials as indicator of brain serotonergic activity—first evidence in behaving cats. Biol Psychiatry 41(12):1181–1195

    Article  PubMed  CAS  Google Scholar 

  • Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G (1999) Auditory evoked potentials reflect serotonergic neuronal activity—a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21(6):710–716

    Article  PubMed  CAS  Google Scholar 

  • Juckel G, Pogarell O, Augustin H, Mulert C, Muller-Siecheneder F, Frodl T et al (2007) Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 68(8):1206–1212

    Article  PubMed  Google Scholar 

  • Juckel G, Gudlowski Y, Muller D, Ozgurdal S, Brune M, Gallinat J et al (2008a) Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia—a replication study. Psychiatry Res 158(1):79–82

    Google Scholar 

  • Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Wutzler A, Schuhmacher C et al (2008b) Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet 147B(4):454–458

    Article  Google Scholar 

  • Juckel G, Kawohl W, Giegling I, Mavrogiorgou P, Winter C, Pogarell O et al (2008c) Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials. Hum Psychopharmacol 23(2):115–120

    Article  Google Scholar 

  • Juckel G, Schumacher C, Giegling I, Assion HJ, Mavrogiorgou P, Pogarell O et al (2010) Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene. J Psychiatr Res 44(8):541–546

    Article  PubMed  Google Scholar 

  • Kahkonen S, Ahveninen J (2002) Combination of magneto- and electroencephalography in studies of monoamine modulation on attention. Methods Find Exp Clin Pharmacol 24(Suppl C):27–34

    PubMed  CAS  Google Scholar 

  • Keers R, Uher R, Huezo-Diaz P, Smith R, Jaffee S, Rietschel M, et al. (2010) Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Pharmacogenomics J [Epub ahead of print]

  • Kikuchi H, Nakatani Y, Seki Y, Yu X, Sekiyama T, Sato-Suzuki I et al (2010) Decreased blood serotonin in the premenstrual phase enhances negative mood in healthy women. J Psychosom Obstet Gynaecol 31(2):83–89

    Article  PubMed  Google Scholar 

  • Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC et al (1998) Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155(3):373–379

    PubMed  CAS  Google Scholar 

  • Lang UE, Hellweg R, Gallinat J (2005) Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 30(6):1148–1153

    Article  PubMed  CAS  Google Scholar 

  • Massey AE, Marsh VR, McAllister-Williams RH (2004) Lack of effect of tryptophan depletion on the loudness dependency of auditory event related potentials in healthy volunteers. Biol Psychol 65(2):137–145

    Article  PubMed  CAS  Google Scholar 

  • McCloskey MS, Berman ME, Echevarria DJ, Coccaro EF (2009) Effects of acute alcohol intoxication and paroxetine on aggression in men. Alcohol Clin Exp Res 33(4):581–590

    Article  PubMed  CAS  Google Scholar 

  • Miller GA, Gratton G, Yee CM (1988) Generalized implementation of an eye movement correction procedure. Psychophysiology 25(2):241–243

    Article  Google Scholar 

  • Mombereau C, Gur TL, Onksen J, Blendy JA (2010) Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol 13(3):321–334

    Article  PubMed  CAS  Google Scholar 

  • Mulert C, Jäger L, Propp S, Karch S, Störmann S, Pogarell O et al (2005) Sound level dependence of the primary auditory cortex: simultaneous measurement with 61-channel EEG and fMRI. Neuroimage 28(1):49–58

    Article  PubMed  Google Scholar 

  • Mulert C, Juckel G, Brunnmeier M, Karch S, Leicht G, Mergl R et al (2007) Prediction of treatment response in major depression: integration of concepts. J Affect Disord 98(3):215–225

    Article  PubMed  CAS  Google Scholar 

  • Nathan PJ, Segrave R, Phan KL, O’Neill B, Croft RJ (2006) Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21(1):47–52

    Article  PubMed  CAS  Google Scholar 

  • Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al (2002) Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59(7):613–620

    Article  PubMed  CAS  Google Scholar 

  • NHMRC (2007) National statement on ethical conduct in human research. National Health and Medical Research Council, Canberra

    Google Scholar 

  • Norra C, Becker S, Brocheler A, Kawohl W, Kunert HJ, Buchner H (2008) Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 23(1):31–42

    Article  PubMed  Google Scholar 

  • O’Neill BV, Croft RJ, Leung S, Guille V, Galloway M, Phan KL et al (2006) Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology (Berl) 188(1):92–99

    Article  Google Scholar 

  • O’Neill BV, Croft RJ, Leung S, Oliver C, Phan KL, Nathan PJ (2007) High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. Psychopharmacology (Berl) 195(1):85–93

    Article  Google Scholar 

  • O’Neill BV, Croft RJ, Nathan PJ (2008a) The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol 23(5):355–370

    Article  Google Scholar 

  • O’Neill BV, Guille V, Croft RJ, Leung S, Scholes KE, Phan KL et al (2008b) Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol 23(4):301–312

    Article  Google Scholar 

  • Owens MJ, Knight DL, Nemeroff CB (2001) Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50(5):345–350

    Article  PubMed  CAS  Google Scholar 

  • Park YM, Lee SH, Kim S, Bae SM (2010) The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 34(2):313–316

    Article  PubMed  Google Scholar 

  • Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G et al (2004) Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29(10):1910–1917

    Article  PubMed  CAS  Google Scholar 

  • Preskorn SH (1996) Clinical pharmacology of SSRI’s (first ed.). Professional Communications, Caddo

  • Puerta E, Hervias I, Aguirre N (2009) On the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg. Neuropsychobiology 60(3–4):119–129

    Article  PubMed  CAS  Google Scholar 

  • Riedel WJ, Eikmans K, Heldens A, Schmitt JA (2005) Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J Psychopharmacol 19(1):12–20

    Article  PubMed  CAS  Google Scholar 

  • Ronfeld RA, Wilner KD, Baris BA (1997) Sertraline. Chronopharmacokinetics and the effect of coadministration with food. Clin Pharmacokinet 32(Suppl 1):50–55

    Article  PubMed  CAS  Google Scholar 

  • Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ (2002) Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. J Psychopharmacol 16(3):207–214

    Article  PubMed  CAS  Google Scholar 

  • Segrave R, Croft RJ, Illic S, Luan Phan K, Nathan PJ (2006) Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation. Pharmacol Biochem Behav 85(1):82–90

    Article  PubMed  CAS  Google Scholar 

  • Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J (2003) Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 53(4):304–314

    Article  PubMed  CAS  Google Scholar 

  • Simmons JG, Allen NB, Judd FK, Norman TR (2000) Serotonin and emotion: a psychophysiological evaluation. Psychophysiology 37:S90

    Article  Google Scholar 

  • Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3(6):508–511

    Article  PubMed  CAS  Google Scholar 

  • Tse WS, Bond AJ (2001) Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacology 15(3):195–198

    Article  CAS  Google Scholar 

  • Tse WS, Bond AJ (2002) Difference in serotonergic and noradrenergic regulation of human social behaviours. Psychopharmacology (Berlin) 159(2):216–221

    Article  CAS  Google Scholar 

  • Tuchtenhagen F, Daumann J, Norra C, Gobbele R, Becker S, Pelz S et al (2000) High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22(6):608–617

    Article  PubMed  CAS  Google Scholar 

  • Uhl I, Gorynia I, Gallinat J, Mulert C, Wutzler A, Heinz A et al (2006) Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21(7):463–471

    Article  PubMed  CAS  Google Scholar 

  • Vaughan HG Jr, Ritter W (1970) The sources of auditory evoked responses recorded from the human scalp. Electroencephalogr Clin Neurophysiol 28(4):360–367

    Article  PubMed  Google Scholar 

  • Watson D, Clark L, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:1063–1070

    Article  PubMed  CAS  Google Scholar 

  • Wutzler A, Winter C, Kitzrow W, Uhl I, Wolf RJ, Heinz A et al (2008) Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 33(13):3176–3181

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge and thank Prof. Trevor Norman for carrying out plasma drug assays and Dr Ric Anney for genotyping samples. Partial funding for this study was received through the University of Melbourne Small Medical Grants Scheme. All recruitment and experimental protocols conducted comply with Australian laws. The authors have full control of all primary data and agree to allow the journal to review the data.

Declarations/conflicts

PJN is an employee of GlaxoSmithKline Pharmaceuticals and holds shares in the company. No other conflicts of interest to report.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas B. Allen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Simmons, J.G., Nathan, P.J., Berger, G. et al. Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants. Psychopharmacology 217, 101–110 (2011). https://doi.org/10.1007/s00213-011-2265-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-011-2265-9

Keywords

Navigation